High disease activity is associated with high disease damage in an Iranian inception cohort of patients with lupus nephritis

被引:0
|
作者
Shariati-Sarabi, Z. [1 ]
Monzavi, S. M. [2 ]
Ranjbar, A. [2 ]
Esmaily, H. [3 ]
Etemadrezaie, H. [4 ]
机构
[1] Mashhad Univ Med Sci, Sch Med, Dept Internal Med, Div Rheumatol, Mashhad, Iran
[2] Mashhad Univ Med Sci, Sch Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Mashhad, Iran
[4] Mashhad Univ Med Sci, Sch Med, Dept Neurosurg, Mashhad, Iran
关键词
SLEDAI; ECLAM; SDI; lupus nephritis; medication adherence; CONSENSUS-STUDY-GROUP; QUALITY-OF-LIFE; ACTIVITY INDEXES; SOCIOECONOMIC-STATUS; RHEUMATOLOGY RESEARCH; EUROPEAN WORKSHOP; RISK-FACTORS; ERYTHEMATOSUS; RACE; VALIDATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This paper aims to determine disease activity and damage in patients with lupus nephritis (LN) and to evaluate the correlation among these domains and sociodemographic features. Methods This study was carried out on 71 lupus patients who were candidate for kidney biopsy due to their clinical renal manifestations. Clinical and sociodemographic data were collected and the Systemic Lupus Erythaematosus Disease Activity Index (SLEDAI-2K updated version), European Consensus Lupus Activity Measurement (ECLAM) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) were assessed after 10 days of admission, the day prior to performing renal biopsy. Results Sixty-five females (91.5%) and six males (8.5%) were studied. Their age was 24 (21-32) yr and disease duration was 1.5 (0.8-4) yr (median [IQR]). SLEDAI-2K, ECLAM and SDI scores were 25.5 +/- 12.3, 6.21 +/- 2.45, 2.0 +/- 2.3 (mean +/- SD) respectively. A great relationship between SLEDAI-2K and ECLAM (r = 0.827, p<0.001) was found. SDI was significantly associated with SLEDAI-2K (r = 0.742, p<0.001) and ECLAM (r = 0.699, p<0.001). Age, gender and disease duration had no significant impact on SLEDAI-2K and ECLAM, while SDI was significantly higher in subjects with longer disease duration particularly in those of more than 3 years. Patients with lower education attainment had less medication adherence and higher disease activity and damage. Conclusion There is a highly significant correlation of high disease activity with cumulative damage in patients with LN, particularly in those with newly-onset disease. Considering that the first years of SLE are an active critical period which can lead to severe damage, this highlights the necessity of aggressive treatment, tight-organised follow-ups and more patient compliance with the physician orders.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 50 条
  • [31] Implications of blood indices in systemic lupus erythematosus patients: Two feasible determinants of disease activity and lupus nephritis
    Aldakhakhny, Samar A.
    Hodeeb, Hossam A.
    El-Gazzar, Nagat M.
    Elwan, Shereen
    EGYPTIAN RHEUMATOLOGIST, 2023, 45 (04) : 285 - 288
  • [32] Urinary and serum neutrophil gelatinase-associated lipocalin as a biomarker in Egyptian systemic lupus erythematosus patients: Relation to lupus nephritis and disease activity
    Tawfik, Yara
    Shaat, Reham M.
    El-Bassiony, Sherif R.
    Hawas, Salah
    Effat, Narmen
    EGYPTIAN RHEUMATOLOGIST, 2015, 37 (04) : S25 - S31
  • [33] Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity
    Stummvoll, Georg H.
    Schmaldienst, Sabine
    Smolen, Josef S.
    Derfler, Kurt
    Biesenbach, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) : 618 - 626
  • [34] Lupus Nephritis: A Different Disease in European Patients?
    Tesar, Vladimir
    Hruskova, Zdenka
    KIDNEY DISEASES, 2015, 1 (02) : 110 - 118
  • [35] Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus
    Touma, Z.
    Gladman, D. D.
    Tulloch-Reid, D.
    Toloza, S. M.
    Ibanez, D.
    Fortin, P. R.
    Urowitz, M. B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 525 - 531
  • [36] Disease activity and damage in hospitalized lupus patients: a Sabah perspective
    Selvananda, S.
    Chong, Y. Y.
    Thundyil, R. J.
    LUPUS, 2020, 29 (03) : 344 - 350
  • [37] Factors Associated With Rapid Progression to Endstage Kidney Disease in Lupus Nephritis
    Tselios, Konstantinos
    Gladman, Dafna D.
    Taheri, Cameron
    Su, Jiandong
    Urowitz, Murray B.
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (02) : 228 - 231
  • [38] Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis
    Zhang, Jing
    Lian, Ruoshan
    Chen, Yi
    Wan, Jianxin
    RENAL FAILURE, 2024, 46 (02)
  • [39] Relationship between serum soluble interleukin 7 receptor and disease activity in patients with lupus nephritis
    Zhou, Shiju
    Jiao, Fengjun
    Zhou, Shengguo
    Li, Xia
    Lv, Lina
    Yang, Xu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 2175 - 2180
  • [40] Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis
    Kamijo, Y.
    Hashimoto, K.
    Takahashi, K.
    Ehara, T.
    Shigematsu, H.
    Higuchi, M.
    CLINICAL NEPHROLOGY, 2011, 76 (02) : 136 - 143